• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NYR

NYRADA INC. - Charts / Financials

6.48% ! 28.8¢
Market Cap $60.63M  !
Healthcare Biotechnology
Add to My Watchlist

Nyrada Inc is an Australia-based drug development company. The Company focuses on... Nyrada Inc is an Australia-based drug development company. The Company focuses on development of small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. Its drug development programs include a proprotein convertase subtilisin/kexin type nine (PCSK9) inhibitor for the treatment of high blood low-density lipoprotein (LDL)-cholesterol levels in patients poorly responsive to or unable to take statin drugs. It develops a neuroprotectant drug to reduce the impact of long-term disability in patients with ischaemic stroke and traumatic brain injury. The Company also develops a drug to treat pain associated with peripheral nerve damage and autoimmune diseases such as psoriasis.More

refresh Created with Sketch. REFRESH
Last update - 11.04am 14/07/2025 (20 minute delay) ?
Day
Open 28.0¢   Day High 29.0¢   Day Low 28.0¢
Daily Volume 77755
Bids   Sellers
Number Price Volume   Number Price Volume
2 28.5¢ 6616   2 29.0¢ 69617

Data source: Refinitiv

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
28.8¢ 		Change
0.018(6.48%) 		Mkt cap ! $60.63M
Open High Low Value Volume
28.0¢ 29.0¢ 28.0¢ $21.89K 77.75K

Buyers (Bids)

No. Vol. Price($)
2 6616 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 69617 2
View Market Depth
Last trade - 11.23am 14/07/2025 (20 minute delay) ?
Last
29.0¢ 		  Change
0.018 ( 5.88 %)
Open High Low Volume
29.0¢ 29.0¢ 29.0¢ 17617
Last updated 11.04am 14/07/2025 ?

Top Stories

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Welcome to this week’s HotCopperWire, our market watch podcast! Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through the week’s biggest news headlines @ and what they mean for Oz investors.In this Week 28 epis...
Inside the depths of Panasqueira: A legacy carved in rock Go deep inside Almonty Industries' Panasqueira Mine in Portugal and discover the people, precision, and power behind one of the world’s most enduring and strategic mining operations.
Athena, Fenix, and Warradarge come together for Mid West Green Iron triumvirate Athena Resources (ASX:AHN) has partnered with Fenix Resources (ASX:FEX) and Warradarge Energy to plan and build its Mid West Green Iron Project, splitting the development three equal ways in a Western Australian triumvirate.Listen to the HotCopper podcast for in-depth discussions and insights on ...
Trigg up +10% on antimony target boost; fieldwork kicks off Trigg Minerals (ASX:TMG) has climbed to 8.4cps in morning trades, a jump of +10%, after posting an upgraded antimony exploration target of between 96,000 and 234,000 tonnes.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week....
Monday's HotCopper trends: Imugene responses, Trigg upgrade | July 14 Imugene (ASX:IMU) has been the talk of the HotCopper forums today, with the much-followed immune-oncology researcher seeing two more complete responses (and three partial responses) in its azer-cel CAR T phase 1b trials.Listen to the HotCopper podcast for in-depth discussions and insights on all ...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.